Hospital
SSM Health Care of Wisconsin INC
SSM Health Care of Wisconsin INC was paid $9.78M by Medicaid between Jan 2018 and Dec 2024, across 199 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.
33Billing provider infoSSM HEALTH CARE OF WISCONSIN INC
BARABOO, WI 53913
BARABOO, WI 53913
33aNPI1386641207assigned 07/07/2005
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$9.78M
24GClaims414,115
24DCodes billed199
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,356 | $1.39M | |
| 2019 | 57,672 | $1.38M | |
| 2020 | 51,053 | $1.20M | |
| 2021 | 69,985 | $1.63M | |
| 2022 | 66,822 | $1.46M | |
| 2023 | 67,109 | $1.55M | |
| 2024incomplete | 51,118 | $1.16M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 20,823 | 18,528 | $1.40M |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.7% | 6,826 | 5,627 | $757K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.0% | 10,936 | 9,644 | $588K |
| 80053 | Comprehensive metabolic panel | 5.6% | 16,476 | 13,851 | $550K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.6% | 6,473 | 5,998 | $454K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.5% | 6,431 | 5,885 | $436K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.7% | 4,899 | 2,247 | $358K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.0% | 11,257 | 3,839 | $292K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.8% | 8,601 | 7,376 | $274K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 2,940 | 2,724 | $247K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.5% | 5,548 | 4,878 | $242K |
| 80306 | 2.4% | 8,335 | 6,303 | $236K |
187 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.3% | 3,495 | $222K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 3,272 | $211K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 2,973 | $187K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.5% | 1,370 | $145K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 19,302 | $126K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 3,140 | $124K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.3% | 2,074 | $124K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 2,613 | $112K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,280 | $91K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,097 | $88K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,406 | $84K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,168 | $83K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,087 | $82K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,419 | $79K |
| 84703 | <1% | 5,116 | $75K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,923 | $71K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,169 | $70K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,052 | $68K |
| 80061 | Lipid panel | <1% | 3,668 | $68K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,733 | $64K |
| 76801 | <1% | 812 | $62K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,241 | $59K |
| 85027 | <1% | 6,876 | $58K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,187 | $58K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,606 | $48K |
| 87081 | <1% | 1,850 | $48K | |
| 82962 | <1% | 5,942 | $48K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,183 | $47K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 681 | $46K |
| 85610 | <1% | 3,550 | $45K | |
| 84484 | <1% | 6,124 | $43K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 471 | $42K |
| 81001 | <1% | 7,890 | $39K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,851 | $39K |
| 80050 | General health panel | <1% | 1,965 | $39K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 441 | $39K |
| 83880 | <1% | 2,043 | $38K | |
| 84702 | <1% | 616 | $36K | |
| 97162 | <1% | 1,158 | $35K | |
| 83605 | <1% | 4,597 | $33K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,614 | $32K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 723 | $32K |
| 86803 | <1% | 1,459 | $30K | |
| 81003 | <1% | 4,582 | $27K | |
| 83690 | <1% | 4,878 | $25K | |
| 86850 | <1% | 2,245 | $24K | |
| 87205 | <1% | 2,359 | $23K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,701 | $23K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,147 | $23K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 404 | $23K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 244 | $21K |
| 87077 | <1% | 1,851 | $21K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 272 | $20K |
| 82805 | <1% | 495 | $19K | |
| 82077 | <1% | 1,835 | $19K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,117 | $17K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 285 | $17K |
| 87631 | <1% | 118 | $17K | |
| 83735 | <1% | 3,298 | $16K | |
| 84439 | <1% | 875 | $16K | |
| 80143 | <1% | 889 | $16K | |
| 82728 | <1% | 877 | $15K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 104 | $15K |
| 87186 | <1% | 1,539 | $14K | |
| 87808 | <1% | 898 | $14K | |
| 86140 | <1% | 2,119 | $13K | |
| 86592 | <1% | 525 | $13K | |
| 73630 | <1% | 1,487 | $13K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,241 | $13K |
| 84145 | <1% | 982 | $12K | |
| 59025 | Fetal non-stress test | <1% | 126 | $12K |
| 76830 | Ultrasound, transvaginal | <1% | 299 | $11K |
| 82607 | <1% | 776 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 455 | $10K |
| 87040 | <1% | 1,784 | $10K | |
| 81025 | <1% | 770 | $9K | |
| 97161 | <1% | 247 | $9K | |
| 87340 | <1% | 1,049 | $9K | |
| 73610 | <1% | 947 | $9K | |
| 83540 | <1% | 703 | $9K | |
| 82565 | <1% | 581 | $9K | |
| 80179 | <1% | 828 | $8K | |
| 84466 | <1% | 690 | $7K | |
| 73110 | <1% | 456 | $7K | |
| 80076 | <1% | 206 | $7K | |
| 85379 | <1% | 952 | $7K | |
| 73030 | <1% | 742 | $7K | |
| 88720 | <1% | 167 | $7K | |
| 12001 | <1% | 70 | $7K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 280 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,574 | $6K |
| 86900 | <1% | 2,121 | $5K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 481 | $5K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 66 | $5K |
| 82950 | <1% | 93 | $5K | |
| G0378 | Hospital observation service, per hour | <1% | 243 | $4K |
| 86901 | <1% | 2,128 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 13 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,626 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,132 | $4K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 177 | $4K |
| 85652 | <1% | 1,347 | $4K | |
| 93975 | <1% | 93 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,761 | $3K |
| 73130 | <1% | 474 | $3K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 15 | $3K |
| 93798 | <1% | 72 | $3K | |
| 82550 | <1% | 243 | $3K | |
| 73564 | <1% | 123 | $2K | |
| 82570 | <1% | 516 | $2K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 56 | $2K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 65 | $2K |
| 82746 | <1% | 173 | $2K | |
| 86780 | <1% | 191 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 268 | $2K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 86 | $2K |
| 73502 | <1% | 81 | $2K | |
| 86762 | <1% | 149 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 42 | $2K |
| 76642 | <1% | 76 | $1K | |
| 92557 | <1% | 27 | $1K | |
| 93971 | <1% | 52 | $1K | |
| 87634 | <1% | 20 | $1K | |
| 83655 | <1% | 56 | $1K | |
| 82043 | <1% | 194 | $1K | |
| 86618 | <1% | 56 | $1K | |
| 93017 | <1% | 26 | $998.49 | |
| 97116 | <1% | 78 | $986.08 | |
| 88142 | <1% | 57 | $947.41 | |
| 86706 | <1% | 55 | $851.78 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,336 | $838.49 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,908 | $798.40 |
| 87522 | Neg quan hep c or qual rna | <1% | 13 | $771.81 |
| 71250 | <1% | 33 | $655.09 | |
| 87807 | <1% | 18 | $519.18 | |
| 96376 | <1% | 1,379 | $448.26 | |
| 84156 | <1% | 50 | $426.64 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 29 | $396.76 |
| 87070 | <1% | 67 | $384.85 | |
| 84460 | <1% | 99 | $376.88 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,950 | $349.93 |
| 77065 | Tomosynthesis, mammo | <1% | 15 | $349.74 |
| 86705 | <1% | 27 | $316.16 | |
| 90715 | <1% | 55 | $313.87 | |
| A9270 | Non-covered item or service | <1% | 2,956 | $282.17 |
| 85730 | <1% | 67 | $274.52 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 47 | $233.01 |
| 73562 | <1% | 351 | $210.54 | |
| 77066 | Tomosynthesis, mammo | <1% | 15 | $172.40 |
| 84550 | <1% | 40 | $151.70 | |
| 72100 | <1% | 25 | $132.31 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,645 | $131.53 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,134 | $73.06 |
| 85018 | <1% | 42 | $72.18 | |
| 94726 | <1% | 13 | $71.10 | |
| 99292 | <1% | 325 | $55.99 | |
| 0352U | <1% | 137 | $51.18 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 107 | $39.89 |
| 94729 | <1% | 13 | $35.58 | |
| 36416 | <1% | 199 | $28.93 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,014 | $5.32 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,341 | $4.30 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,829 | $3.49 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,153 | $2.85 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,024 | $2.79 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,026 | $2.40 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,666 | $1.08 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,273 | $0.95 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 68 | $0.86 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,008 | $0.86 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 822 | $0.72 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 105 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 125 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 54 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 15 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 113 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 26 | $0.00 |
| 73590 | 0% | 15 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 4,298 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,143 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 392 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 92 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 1,698 | $0.00 |
| J3490 | Unclassified drugs | 0% | 71 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 135 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 20 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 0% | 111 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMINERATH, JOSEPH (SYSTEM DIRECTOR GOV'T REIMBURSEMENT)
| Provider | Location | Paid |
|---|---|---|
| SSM Health Care of Wisconsin, INC. | Madison, WI | $14.70M |
| SSM Health Care of Wisconsin, INC. | Janesville, WI | $8.37M |
| SSM Health Care of Wisconsin, INC | Madison, WI | $6.40M |
| Ripon Medical Center INC | Ripon, WI | $4.30M |
| Agnesian Healthcare INC | Fond Du Lac, WI | $2.25M |
| SSM Health Care of Wisconsin INC | Janesville, WI | $1.03M |
| Agnesian Healthcare INC | Fond Du Lac, WI | $172K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.